Project description
Novel pan-European imaging platform for artificial intelligence advances in oncology
The goal of the EU-funded EuCanImage project is to build a secure, large-scale European cancer imaging platform with capabilities that will advance the application of artificial intelligence (AI) in oncology. The platform will be populated with new data from 25 000 subjects, enabling the investigation of unmet clinical needs, such as the detection of small liver lesions and metastases of colorectal cancer or the evaluation of the molecular subtypes of breast tumours. The platform will be cross-linked to biological and health repositories through the European Genome–phenome Archive, allowing the development of multiscale AI solutions that integrate organ-level, molecular and clinical predictors into novel patient-specific cancer fingerprints. The consortium will build upon several European initiatives in data sharing for personalised medicine research.
Objective
The goal of EuCanImage is to build a highly secure, federated and large-scale European cancer imaging platform, with capabilities that will greatly enhance the potential of artificial intelligence (AI) in oncology. Firstly, the EuCanImage platform will be populated with a completely new data resource totaling over 25,000 single subjects, which will allow to investigate unmet clinical needs like never before, such as for the detection of small liver lesions and metastases of colorectal cancer, or for estimating molecular subtypes of breast tumours and pathological complete response. Secondly, the cancer imaging platform, built by leveraging the well-established Euro-Bioimaging infrastructure, will be cross-linked to biological and health repositories through the European Genome-phenome Archive, allowing to develop multi-scale AI solutions that integrate organ-level, molecular and other clinical predictors into dense patient-specific cancer fingerprints.
To deliver this platform, the consortium will build upon several key European initiatives in data sharing for personalised medicine research, including EUCANCAn (cancer genomics and health data sharing), euCanSHare (cardiac imaging and omics data sharing) and EUCAN-Connect (federated data analytics). Furthermore, to foster international cooperation and leverage existing success stories, the consortium comprises the coordinators of The Cancer Imaging Archive (TCIA), the US cancer imaging repository funded by the National Cancer Institute. This will allow EuCanImage to leverage a unique 10-year long experience in cancer imaging storage, anonymisation, curation and management. Finally, a close collaboration between world renown clinical, radiomics, AI and legal experts within the consortium and beyond will establish well-needed guidelines for AI development and validation named FUTURE, for delivering Fair, Universal, Traceable, Usable, Robust and Explainable decision support systems for future cancer care.
Fields of science
Keywords
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
08007 Barcelona
Spain
See on map
Participants (21)
6200 MD Maastricht
See on map
3015 GD Rotterdam
See on map
08034 Barcelona
See on map
08003 Barcelona
See on map
72701 Fayetteville
See on map
8010 Graz
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
10117 Berlin
See on map
48940 Leioa
See on map
00198 Rome
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
182 33 DANDERYD
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4000 LIEGE
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
91052 Erlangen
See on map
1010 Wien
See on map
1010 Wien
See on map
NG7 2TU Nottingham
See on map
56126 Pisa
See on map
08036 Barcelona
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
08036 Barcelona
See on map
901 87 Umea
See on map
80210 Gdansk
See on map
50161 KAUNAS
See on map